195990 — ABPro Bio Co Income Statement

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeSmall CapSucker Stock

Annual income statement for ABPro Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	31,930	35,797	32,914	22,112	25,375
Cost of Revenue
Gross Profit	-12,680	5,602	3,928	1,619	1,269
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	64,398	46,440	37,875	22,612	35,270
Operating Profit	-32,468	-10,643	-4,961	-500	-9,894
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-37,098	-41,207	-9,675	-8,145	-25,658
Provision for Income Taxes
Net Income After Taxes	-34,498	-44,755	-9,740	-8,145	-25,742
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-37,869	-58,972	-10,030	-8,145	-25,742
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-37,869	-58,972	-10,030	-8,145	-25,742
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-240	-171	-38.7	-61.1	-89.8
Dividends per Share